NR3C2 and cancer: Dysregulated post-MR signaling is associated with unregulated cell proliferation and cancer progression (Chen et al., 2019), an “overactive” bladder (Abrams et al., 2006), autoimmune diseases (Berg et al., 2010; Lee et al., 2013) and psychiatric disorders (Scarr, 2012; Vakalopoulos, 2014; Jeon et al., 2015).